Genomic & Biopharma News

First New Tuberculosis Drug Approved in 50 Years
The US Food and Drug Administration green lights a therapy for an extreme form of multidrug resistant TB.
The Scientist, 2019-08-15 14:10:39

Pfizer recalls migraine med Relpax because of bacterial contamination
After an earlier recall of Relpax, Pfizer is again tracking down a couple of lots of the migraine headache med. This time, it's because the affected drugs may be contaminated with bacteria that could cause fatal infections in some patients.
Fierce Pharma, 2019-08-15 14:04:18

V-Wave nabs FDA breakthrough designation for its heart pressure shunt implant
V-Wave has received a breakthrough device designation from the FDA for its interatrial shunt being tested for heart failure.
Fierce Biotech, 2019-08-15 14:02:42

Celebration to Commemorate Ocean Ridge Biosciences' Re-Opening at New Facility
Ocean Ridge Biosciences (ORB), a leader in RNA profiling and biomarker discovery services, will celebrate a grand re-opening at its new location, 394 SW 12th Avenue, Deerfield Beach, Florida. The event will take place on Friday, November 18th, 2016 from 5:00PM to 8:00PM. Please read the PDF for more details
ORB Company News, 2016-11-14 17:41:06

Teva shares approach 20-year low amid Moody's warning and other woes
Debt-rating firm Moody's revised its Teva outlook from "stable" to "negative" as the company deals with challenges ranging from opioid lawsuits to a congressional price-fixing probe to declining Copaxone sales. Investors were none too happy.
Fierce Pharma, 2019-08-15 13:53:55

In conversation with Samumed CEO Osman Kibar: Drugging Wnt, restoring youth and unconventional capital
Samumed CEO Osman Kibar discusses regenerative medicine, drugging the Wnt pathway and his company's unorthodox journey.
Fierce Biotech, 2019-08-15 13:33:27

Herpes treatment greatly improved by adding charcoal
A novel charcoal-based drug-delivery system to treat herpes infections topically shows greatly improved efficacy over conventional treatment. Here, the medication called acyclovir, commonly used for herpes infection, was combined with activated carbon particles.
News Medical Life Sciences, 2019-08-15 13:19:55

ORB relocates to Deerfield Beach and celebrates grand opening of new facility with local researchers
After 8 years of operation in Palm Beach Gardens, Ocean Ridge Biosciences (ORB) has recently relocated to a 5,394 sq. ft. facility in Deerfield Beach, Florida. The new facility provides several improvements which will enable ORB to provide improved and expanded services to academic and corporate clients. These include:
ORB Company Blog, 2016-11-21 19:26:55

FDA approves effective new treatment for extremely drug-resistant tuberculosis
Tuberculosis is the leading infectious killer in the world, far above AIDS. It kills about 1.6 million of the 10 million it affects every year. About 30,000 patients worldwide now have XDR tuberculosis (that fails to respond to any of the four antibiotic categories in use at present).
News Medical Life Sciences, 2019-08-15 13:01:00

Ultragenyx snags option on antisense startup GeneTx
Ultragenyx has picked up an option to acquire GeneTx and its preclinical antisense oligonucleotide. The drug, GTX-102, is designed to treat the rare neurogenetic disorder Angelman syndrome.
Fierce Biotech, 2019-08-15 12:55:52

Emcure knocked by the FDA for sterility issues after injectable drug recall
Emcure Pharmaceuticals has had its share of run-ins with the FDA in the past over the sterility of its Indian manufacturing plant. Now, it can notch one more black mark on its belt.
Fierce Pharma, 2019-08-15 12:51:41